fda English news | fda, Latest News & Live Updates in English | English News (Latest English News) at Lokmattimes.com

"I discovered that a cloud hovered over the company. American regulators were investigating whether Ranbaxy had fabricated quality data in order to gain approval to market its drugs. The allegations had first been made by a company whistleblower who had contacted the agency (FDA)," Eban, who travelled halfway across the globe as part of her investigations, writes in "Bottle of Lies - Ranbaxy and the Dark Side of Indian Pharma" (Juggernaut/pp 482/Rs 699).The whistleblower in question, says Eban, is Dinesh Thakur, then Ranbaxy's Director and Global Head of Research, Information and Portfolio Management, who, in 2004, put together a team to study a deadly secret he had come across: that the company was fudging data."Little by little, as the team members stitched together small bits of information, they stumbled into Ranbaxy's secret: the company manupulated almost every aspect of its manufacturing process to quickly produce impressive looking data that would bolster its bottom line," Eban writes."Each member of Thakur's team came back with similar examples. At the behest of managers, the company's scientists substituted lower-purity ingredients for higher ones to reduce costs. They altered test parameters so that formulations with higher impurities could be approved. They faked dissolution studies. To generate optimal results, they crushed up brand-name drugs into capsules so that they could be tested in lieu of the company's own drugs. They superimposed brand-name test results onto their own in applications," the book says.Noting that document forgery "was pervasive", the book says: "The company even forged its own standard operating procedures, which FDA investigators rely on to assess whether a company is following its own policies. In one instance, employees backdated documents and then artificially aged them in a steamy room overnight in an attempt to fool regulators during inspections", the book says.Essentially, Ranbaxy's manufacturing standards "boiled down to whatever the company could get away with", the book says.Thakur worked 14-hour days and after weeks of exhaustive research, brought his team's preliminary findings to his boss, Raj Kumar."Once Kumar heard from each member of Thakur's team, it finally sank in. The company was committing fraud and potentially harming patients on a global scale. He distilled the information into a four-page report for the CEO, Brian Tempest," that "laid bare systematic fraud in Ranbaxy's worldwide regulatory filings", the book says.Predictably, there was no action as the findings "were not news to Ranbaxy's top executives", Eban writes in the book , and when Thakur pressed the issue, the company fought back in a rather unusual manner: It accused him of downloading pornography on his office computer.Thakur realised he had to go but agonised on what to do next. He made his first move, masking his identity, on the morning of August 15, 2005 but when there was no action for two weeks, he sent a message directly to FDA Commissioner Lester Crawford, the book says. The result was immediate and set in motion a chain of events that culminated in May 2013 with Ranbaxy pleading guilty to felony charges in the manufacture and distribution of certain adulterated drugs made at two of its facilities in India, and misrepresenting clinical generic drug data."In the largest drug safety settlement to date with a generic drug manufacturer... Ranbaxy also agreed to pay a criminal fine and forfeiture totaling $150 million and to settle civil claims under the False Claims Act and related State laws for $350 million," the Justice Department said in a statement on May 13, 2013.Ranbaxy also pleaded guilty to three felony FDCA (Food Drug and Cosmetic Act) counts, and four felony counts of knowingly making material false statements to the FDA. Among the adulterated products were antiretroviral (ARV) drugs destined for treatment of HIV/AIDS in Africa.In this context, the book notes that the endorsement in November 2013 of Ranbaxy and other Indian pharma companies by former US President Bill Clinton for their efforts at producing low-cost generics had set the sales of the ARV drugs zooming.In the midst of all this, Ranbaxy initially passed into the hands of Japan's Daiichi-Sankyo in November 2008 and was bought over in April 2014 by India's Sun Pharmaceutical.In February, the Supreme Court asked the company's former owners, Malvinder Mohan Singh and his brother Shivinder to cough up the Rs 35 billion they owe to Daiichi Sankyo in compensation post its exit from the company - warning they could be jailed if they failed to do so.( With inputs from IANS )

FdaFOLLOW

Fda, Latest News

Pancreatic cancer is resistant to all current treatments. Patients have extremely poor chances of surviving for five years after being diagnosed but a new study found that a small molecule has the ability to induce the self-destruction of pancreatic ...

6 Given the increase in adolescents' use of tobacco products, especially electronic cigarettes, experts have called for education "based on facts and not on emotions" and increased regulation on retailers to curb the menace of vaping. ...

After the US health regulators found traces of asbestos in samples from Johnson & Johnson (J&J) baby powder and forced the company to recall 33,000 bottles of talcum powder, physic in India have warned that long-term exposure of asbestos can trigger ...

The Trump administration said that it plans to bar the sale of non-tobacco-flavoured e-cigarettes in the United States following six deaths linked to vaping. ...

A Zika diagnostic test developed by Washington University School of Medicine in St. Louis was newly granted market authoriSation by the Food and Drug Administration (FDA). ...

Taking cognizance of a media report that exposed how Amazon facilitated trade of unsafe, banned products on its platform, three lawmakers in the US have written to the e-commerce giant's CEO Jeff Bezos, urging him to take swift action to stop wrongfu ...

In a first of its kind initiative, hotels, restaurants and eateries in Maharashtra will soon have to make a mandatory mention of the 'calorie count' of all the food items served to the patrons on grounds of health and helping the customers make infor ...

American investigative journalist Katherine Eban pored over roughly 20,000 internal documents from the US FDA, including emails, memorandums, minutes of meetings and thousands of internal government records, as also replies under the Freedom of Infor ...